New research reports that ultrasonography predicts absence of clinical flare following discontinuation of biologic therapy in patients with rheumatoid arthritis in clinical remission. Other studies also support the inclusion of ultrasonography and MRI in future remission criteria. Ongoing studies to clarify clinical and structural damage benefits of imaging-based treat-to-target strategies are awaited.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?
Arthritis Research & Therapy Open Access 30 January 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Iwamoto, T. et al. Ultrasonographic assessment predicts relapse after discontinuation of biological agents in patients with rheumatoid arthritis in clinical remission. Arthritis Care Res. (Hoboken) http://dx.doi.org/10.1002/acr.22303.
Haavardsholm, E. A., Lie, E. & Lillegraven, S. Should modern imaging be part of remission criteria in rheumatoid arthritis? Best Pract. Res. Clin. Rheumatol. 26, 767–785 (2012).
Brown, A. K. et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 54, 3761–3773 (2006).
Brown, A. K. et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 58, 2958–2967 (2008).
Foltz, V. et al. Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum. 64, 67–76 (2012).
Gandjbakhch, F. et al. Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity. J. Rheumatol. 41, 398–406 (2014).
Scirè, C. A. et al. Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. Rheumatology (Oxford) 48, 1092–1097 (2009).
Colebatch, A. N. et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum. Dis. 72, 804–814 (2013).
Saleem, B. et al. Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped? Ann. Rheum. Dis. 69, 1636–1642 (2010).
Axelsen, M. B. et al. Whole-body MRI assessment of disease activity and structural damage in rheumatoid arthritis: first step towards an MRI joint count. Rheumatology (Oxford) http://dx.doi.org/10.1093/rheumatology/ket425.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Table 1
Overview of clinical trials of imaging-guided treatment strategies for rheumatoid arthritis (DOC 42 kb)
Rights and permissions
About this article
Cite this article
Østergaard, M., Møller-Bisgaard, S. Is imaging needed to define remission in rheumatoid arthritis?. Nat Rev Rheumatol 10, 326–328 (2014). https://doi.org/10.1038/nrrheum.2014.63
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.63
This article is cited by
-
MR and ultrasound of the hands and wrists in rheumatoid arthritis. Part II. Added clinical value
Skeletal Radiology (2019)
-
Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?
Arthritis Research & Therapy (2018)
-
Risk factors of flare in rheumatoid arthritis patients with both clinical and ultrasonographic remission: a retrospective study from China
Clinical Rheumatology (2017)